Post

New research · Neurology
The Journal of neuropsychiatry and clinical neurosciences · 23h
StudyThe Journal of neuropsychiatry and clinical neurosciences · 2026

Survey on the Application Timeline for Behavioral Neurology & Neuropsychiatry Fellowship Programs.

Sylvia Josephy-Hernandez, James R Bateman, Roy H Hamilton
Read paper
NeurologyStudy

Most program directors are open to a unified offer date for fellowships.

Survey on the Application Timeline for Behavioral Neurology & Neuropsychiatry Fellowship Programs.

Sylvia Josephy-Hernandez et al. · The Journal of neuropsychiatry and clinical neurosciences · 2026
Background

Behavioral neurology & neuropsychiatry (BNNP) fellowship programs do not have a coordinated application timeline.

95%
Results
most specialized training program leaders were open to a unified date for job offers
More results

Complete responses were received from 22 PDs and from 11 current and six incoming fellows, within a span of 17 months between the first application opening (August postgraduate year 3) and the last position offering (December postgraduate year 4).

More results

Although not a statistically significant finding, 41% of the fellows reported that different application timelines prevented them from completing interviews for all their desired programs, and 88% agreed with a unified timeline (p=0.002).

“
Conclusion

Most participants recognized challenges because of differing timelines and agreed on unifying one or more aspects of the application process.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Study
more than 3.4 billion people
the global count of people living with brain and nerve conditions
Case Report
81%
patients experienced lower nightmare frequency when taking once-nightly pregabalin
Cross-sectional
RR=1.72 (1.35-2.08)
Risk of Lewy body dementia diagnosis was 1.72 times higher in North East England.
Cohort Study
71.8%
children with D/EE-SWAS achieved freedom from seizures after taking ethosuximide
Study
over 80 cases
documented cases of brain and nerve conditions found in Inquisition records
Cohort Study
27.3%
the highest proportion of patients diagnosed with Charcot-Marie-Tooth disease type 1A
Guideline
“The introduction of the first anti-amyloid mAb represents a paradigm shift in the management of AD, but is not free of challenges.”
Meta-analysis
RR 1.21
extended clot-busting treatment led to a 21% higher chance of excellent recovery from stroke